NRX Pharmaceuticals EPS NRXP

Diluted earnings per share by quarter and over the last twelve months, from 2018.

NRX Pharmaceuticals' twelve-month earnings per share can't be added up yet: a quarter of its results is missing from our data.

In its latest quarter, Q1 FY24, it was −$0.74.

Earnings per share over time

Each fiscal year is the twelve months to its fourth quarter.

Quarter	Ended	EPS	On a year earlier	Last 12 months
Q1 FY24	Mar 31, 2024	−$0.74	n/a	n/a
Q3 FY23	Sep 30, 2023	−$0.70	n/a	−$3.74
Q2 FY23	Jun 30, 2023	−$1.20	n/a	−$4.44
Q1 FY23	Mar 31, 2023	−$0.34	n/a	−$4.34
Q4 FY22	Dec 31, 2022	−$1.50	n/a	−$6.10
Q3 FY22	Sep 30, 2022	−$1.40	n/a	−$9.90
Q2 FY22	Jun 30, 2022	−$1.10	n/a	−$15.70
Q1 FY22	Mar 31, 2022	−$2.10	n/a	−$18.70
Q4 FY21	Dec 31, 2021	−$5.30	n/a	−$23.70
Q3 FY21	Sep 30, 2021	−$7.20	n/a	−$31.00
Q2 FY21	Jun 30, 2021	−$4.10	n/a	−$25.30
Q1 FY21	Mar 31, 2021	−$7.10	−810%	−$21.20

Companies in Drug Manufacturers - General nearest NRX Pharmaceuticals' size, closest first, today.

Company	EPS, 12 months	Growth
NRXPNRX Pharmaceuticals	n/m
LFVNLifevantage	$0.40	−46% a year
SPROSpero Therapeutics	$0.11
NATRNatures Sunshine Products	$1.01	+36% a year
ATNMActinium Pharmaceuticals	$0.36
ARVNArvinas	$0.16
PBYIPuma Biotechnology	$0.52	−47% a year
IRWDIronwood Pharmaceuticals	$0.77
ZVRAZevra Therapeutics	$0.93
CRMDCorMedix	$2.13	+184% a year
COLLCollegium Pharmaceutical	$1.24	+19% a year
Peer median	$0.65